• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1主要中和决定簇的构象偏好

Conformational preferences of the HIV-1 principal neutralizing determinant.

作者信息

Andrianov A M

机构信息

Institute of Bioorganic Chemistry, Belarus Academy of Sciences, ac. Kuprevich St., 5/2, 220141 Minsk, Republic of Belarus.

出版信息

J Biomol Struct Dyn. 2005 Dec;23(3):267-82. doi: 10.1080/07391102.2005.10507065.

DOI:10.1080/07391102.2005.10507065
PMID:16218754
Abstract

The model describing the conformational properties of the HIV-1 principal neutralizing determinant in the geometric space of dihedrals was generated in terms of NMR spectroscopy data published in literature. To gain an object in view, the following successive steps were put into effect: (i) the NMR-based local structures for the HIV(MN) V3 loop were determined in water and in a mixed water/trifluoroethanol (TFE) solvent (7:3), (ii) in either case, the conformations of its irregular segments were analyzed and the secondary structure elements identified, (iii) to appreciate the degree of conformational mobility of the stretch of interest, the simulated structures were compared with each other, (iv) to detect the amino acids retaining their conformations inside the diverse HIV-1 isolates, the structures computed were collated with the one derived previously for the V3 loop from Thailand isolate, and (v) as a matter of record, the structurally rigid residues, that may present the forward-looking targets for AIDS drug researches, were revealed. Summing up the principal results arising from these studies, the following conclusions were drawn: I. The HIV(MN) V3 loop offers the highly mobile fragment of gp120 sensitive to its environment whose changes trigger the large-scale structural reforms, bringing in substantial altering the secondary structure of this functionally important site of the virus envelope. II. In water, it exhibits extended site 1-14 separated by double beta-turn 15-20 with unordered region 21-35. III. Adding the TFE gives rise to destruction of the regular structure in the V3 loop N-terminal, stimulates the formation of 3(10)-helix in site 24-31, and affects also its central region 20-25 forming the HIV-1 immunogenic crown. IV. Regardless of statistically significant differences between local structures of the HIV(MN) V3 loop in water and in water/TFE solution, over one-third of residues keeps their conformational states; the register of these amino acids comprises Asn-25 critical for virus binding with primary cell receptor CD4 as well as Arg-3 critical for utilization of CCR5 coreceptor. V. There are no conserved structural motifs within the V3 loops from Minnesota and Thailand HIV-1 strains. However, perceptible portion of amino acids (more than 35%), including those appearing in the functionally important regions of gp120, holds the values of dihedral angles in which case. The implications are discussed in conjunction with the data on the experimental observations for the HIV-1 principal neutralizing determinant.

摘要

根据文献中发表的核磁共振波谱数据,构建了一个描述HIV-1主要中和决定簇在二面角几何空间中构象性质的模型。为了达成目标,实施了以下连续步骤:(i)在水和水/三氟乙醇(TFE)混合溶剂(7:3)中确定基于核磁共振的HIV(MN)V3环局部结构;(ii)在任何一种情况下,分析其不规则片段的构象并识别二级结构元件;(iii)为了评估感兴趣片段的构象移动程度,将模拟结构相互比较;(iv)为了检测在不同HIV-1分离株中保持其构象的氨基酸,将计算得到的结构与先前从泰国分离株的V3环得到的结构进行比对;(v)作为记录,揭示了可能成为艾滋病药物研究前瞻性靶点的结构刚性残基。总结这些研究得出的主要结果,得出以下结论:I. HIV(MN)V3环提供了gp120的高度可移动片段,对其环境敏感,环境变化会引发大规模结构改革,从而显著改变病毒包膜这一功能重要位点的二级结构。II. 在水中,它呈现出由双β-转角15-20分隔的延伸位点1-14,以及无序区域21-35。III. 添加TFE会导致V3环N端规则结构的破坏,刺激位点24-31中3(10)-螺旋的形成,并且还会影响其形成HIV-1免疫原性冠的中心区域20-25。IV. 无论HIV(MN)V3环在水和水/TFE溶液中的局部结构存在统计学上的显著差异,超过三分之一的残基保持其构象状态;这些氨基酸包括对病毒与初级细胞受体CD4结合至关重要的Asn-25以及对CCR5共受体利用至关重要的Arg-3。V. 来自明尼苏达和泰国HIV-1菌株的V3环内不存在保守的结构基序。然而,相当一部分氨基酸(超过35%),包括那些出现在gp120功能重要区域的氨基酸,在这种情况下保持二面角的值。结合关于HIV-1主要中和决定簇的实验观察数据对这些影响进行了讨论。

相似文献

1
Conformational preferences of the HIV-1 principal neutralizing determinant.HIV-1主要中和决定簇的构象偏好
J Biomol Struct Dyn. 2005 Dec;23(3):267-82. doi: 10.1080/07391102.2005.10507065.
2
Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.人类免疫缺陷病毒1型糖蛋白120 V3环的结构分析:应用于海地的人类免疫缺陷病毒分离株
J Biomol Struct Dyn. 2007 Jun;24(6):597-608. doi: 10.1080/07391102.2007.10507149.
3
Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.HIV-1 A亚型V3环的计算模型:基于结构的抗艾滋病药物设计中的构象流动性研究
J Biomol Struct Dyn. 2009 Oct;27(2):179-93. doi: 10.1080/07391102.2009.10507308.
4
Local structural properties of the V3 loop of Thailand HIV-1 isolate.泰国HIV-1分离株V3环的局部结构特性
J Biomol Struct Dyn. 2002 Jun;19(6):973-89. doi: 10.1080/07391102.2002.10506801.
5
[Conformation of the HIV-1 gp120 V3 loop. Structure functional analysis of the HIV-Haiti viral strain].[人类免疫缺陷病毒1型糖蛋白120 V3环的构象。海地人类免疫缺陷病毒毒株的结构功能分析]
Tsitologiia. 2006;48(11):948-57.
6
Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.确定HIV-1可变V3环的不变结构元件:对HIV-MN和HIV-海地分离株的深入了解。
J Biomol Struct Dyn. 2008 Oct;26(2):247-54. doi: 10.1080/07391102.2008.10507240.
7
Solution structure of the V3 loop of a Thailand HIV isolate.一株泰国HIV分离株V3环的溶液结构
J Biomol Struct Dyn. 1993 Oct;11(2):345-66. doi: 10.1080/07391102.1993.10508731.
8
Dual spatial folds and different local structures of the HIV-1 immunogenic crown in various virus isolates.不同病毒分离株中HIV-1免疫原性冠的双空间折叠和不同局部结构。
J Biomol Struct Dyn. 2004 Oct;22(2):159-70. doi: 10.1080/07391102.2004.10506992.
9
3D structure model of the principal neutralizing epitope of Minnesota HIV-1 isolate.明尼苏达HIV-1分离株主要中和表位的三维结构模型
J Biomol Struct Dyn. 2004 Feb;21(4):577-90. doi: 10.1080/07391102.2004.10506950.
10
Immunophilins and HIV-1 V3 loop for structure-based anti-AIDS drug design.免疫亲和素与 HIV-1 V3 环用于基于结构的抗艾滋病药物设计。
J Biomol Struct Dyn. 2009 Feb;26(4):445-54. doi: 10.1080/07391102.2009.10507259.